(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. \u0010 \u0010GUEST: \u0010Cynthia Koons \u0010Health Care Reporter \u0010Bloomberg Editorial \u0010on Pfizer beating out rivals to buy biopharmaceutical company, Medivation, and its blockbuster cancer drug for $14 billion.

Apple Slides Most Since 2025 After Supply Shortages Hurt Outlook
17:44

Instant Reaction: Apple Slides After Supply Shortages Hurt Its Sales Forecast
10:27

Instant Reaction: Amazon Reports Cloud Sales Growth for Fifth Straight Quarter
18:09